2021
DOI: 10.1177/1934578x211056753
|View full text |Cite
|
Sign up to set email alerts
|

Ayurvedic Medicinal Plants Against COVID-19: AnIn SilicoAnalysis

Abstract: Even after one and a half years since the outbreak of COVID-19, its complete and effective control is still far from being achieved despite vaccination drives, symptomatic management with available drugs, and wider lockdowns. This has inspired researchers to screen potential phytochemicals from medicinal plants against SARS-CoV-2, adopting a bio-informatics approach. The current study aimed to assess anti-viral activity of the phytochemicals derived from Ayurvedic medicinal plants against SARS-CoV-2 drug targe… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
10
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 13 publications
(12 citation statements)
references
References 63 publications
(62 reference statements)
0
10
0
Order By: Relevance
“…65,66 In addition, many studies have investigated whether traditional medicinal plant extracts exhibit anti-SARS-CoV-2 activity. 67-70…”
Section: Discussionmentioning
confidence: 99%
“…65,66 In addition, many studies have investigated whether traditional medicinal plant extracts exhibit anti-SARS-CoV-2 activity. 67-70…”
Section: Discussionmentioning
confidence: 99%
“…19 Bharat Krushna Khuntia et al focused on Picrorhizakurroa (Kutki), Azadirachta indica (Neem) and Cyperusrotundus (Mustak), which are widely used in Ayurveda, and performed in silico analysis to reveal the treatment effect in COVID-19. 20 Huoxiang Zhengqi dropping pills and Lianhua Qingwen granules, which belong to TCM, also showed great advantages in improving the clinical symptoms and prognosis of COVID-19 patients in a randomized controlled trial. 21 Currently, TCM combined with western medicine is applied in more than 90% of COVID-19 patients in China and has shown obvious and effective results.…”
Section: Introductionmentioning
confidence: 99%
“…6,7 Most of the previous studies were from single target and multiple drug backgrounds. 18,19 Nevertheless, in this study, we are reporting N-{2-[(2S)-2-Amino-3-methylbutoxy]-6-pro-pylbenzoyl}-L-phenylalanyl-L-serine (Butoxypheser) 20 as the multitargeted inhibitor that has been identified after comprehensive pipeline-based research. We have performed multilevel screening to reduce the computational costs, ie, High-Throughput Virtual Screening (HTVS), Standard Precision (SP), Extra Precise (XP), and Molecular Mechanics/ Generalized Born Surface Area (MMGBSA).…”
Section: Introductionmentioning
confidence: 99%